This was the first demonstration that a GLP-1R agonist produces cardiovascular benefit independent of glycaemic effects, expanding the research interest in GLP-1R agonism beyond metabolic and weight endpoints
About IGF-1 LR3 1mg IGF-1 LR3, short for Insulin-like Growth Factor-1 Long R3, is a lab-engineered version of the naturally occurring hormone IGF-1
Weight Loss: While weight loss can be a desirable outcome for many individuals with type 2 diabetes, excessive weight loss associated with GLP-1 medications may be problematic for some patients, especially those who are already at a healthy weight or at risk of malnutrition
Snoring or mouth breathing: Breathing through the mouth, especially during sleep, allows air to pass over the lips continuously
Hereafter, I inspect my medication before each use
10.1523/JNEUROSCI.3262-11.2011 29 DruckerD